<img height="1" width="1" src="https://www.facebook.com/tr?id=1582471781774081&amp;ev=PageView &amp;noscript=1">

Frailty Models Better Assess Drug Efficacy in MCTs

Mouse clinical trials (MCTs) use a cohort of patient-derived xenograft (PDX) models to evaluate drug efficacy and discover biomarkers, similar to a Phase II human oncology clinical trial. Also similar to human clinical trials, survival analysis can be used to analyze MCTs.